Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4298 USD | +4.80% | +15.54% | +145.46% |
Business Summary
Number of employees: 17
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 0 | nan % | 12 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 12 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Charles Theuer
CEO | Chief Executive Officer | 60 | 06-06-30 |
Scott Brown
DFI | Director of Finance/CFO | 43 | 15-07-31 |
James L. Freddo
CTO | Chief Tech/Sci/R&D Officer | 69 | 20-04-30 |
Brenda Marczi
LAW | General Counsel | - | 21-07-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Mattingly
BRD | Director/Board Member | 66 | 14-12-25 |
Director/Board Member | 54 | 20-03-18 | |
Stephen Worland
BRD | Director/Board Member | 66 | 15-02-24 |
Rainer Twiford
BRD | Director/Board Member | 71 | 08-08-31 |
William LaRue
BRD | Director/Board Member | 73 | 14-06-30 |
Charles Theuer
CEO | Chief Executive Officer | 60 | 06-06-30 |
Carol Lam
BRD | Director/Board Member | 64 | 21-10-11 |
Director/Board Member | 60 | 21-03-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 45,504,501 | 43,230,434 ( 95.00 %) | 0 | 95.00 % |
Company contact information
TRACON Pharmaceuticals, Inc.
4350 La Jolla Village Drive Suite 800
92122-1243, San Diego
+
http://www.traconpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+145.46% | 18.66M | |
+0.44% | 90.27B | |
+9.61% | 44.05B | |
-16.67% | 31.45B | |
+44.99% | 23.35B | |
-9.42% | 16.72B | |
-25.92% | 15.09B | |
-9.27% | 12.82B | |
-7.57% | 11.95B | |
+0.07% | 8.71B |
- Stock
- Equities
- Stock TRACON Pharmaceuticals, Inc. - Nasdaq
- Company TRACON Pharmaceuticals, Inc.